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Abstract
Background: Stroke is the third leading cause of death in developed countries and the leading cause of long-term
disability worldwide. A series of national stroke audits in the UK highlighted the differences in stroke care between
hospitals. The study aims to describe variation in outcomes following stroke and to identify the characteristics of
services that are associated with better outcomes, after accounting for case mix differences and individual
prognostic factors.
Methods/Design: We will conduct a cohort study in eight acute NHS trusts within East of England, with at least
one year of follow-up after stroke. The study population will be a systematically selected representative sample of
patients admitted with stroke during the study period, recruited within each hospital. We will collect individual
patient data on prognostic characteristics, health care received, outcomes and costs of care and we will also record
relevant characteristics of each provider organisation. The determinants of one year outcome including patient
reported outcome will be assessed statistically with proportional hazards regression models. Self (or proxy)
completed EuroQol (EQ-5D) questionnaires will measure quality of life at baseline and follow-up for cost utility
analyses.
Discussion: This study will provide observational data about health service factors associated with variations in
patient outcomes and health care costs following hospital admission for acute stroke. This will form the basis for
future RCTs by identifying promising health service interventions, assessing the feasibility of recruiting and
following up trial patients, and provide evidence about frequency and variances in outcomes, and intra-cluster
correlation of outcomes, for sample size calculations. The results will inform clinicians, public, service providers,
commissioners and policy makers to drive further improvement in health services which will bring direct benefit to
the patients.
Background
Stroke is the third leading cause of mortality and the
number one cause of long-term disability in the UK.
More than 150,000 people suffer a stroke in the UK
each year [1]. It costs the NHS approximately £ 7 billion
per annum [2]. Stroke incidence rises sharply with age
and despite better primary and secondary preventative
measures, the total number of strokes is set to rise in
the UK [3]. Nevertheless, stroke care in UK is far from
ideal: patients having a worse outcome in terms of
death and dependency than many other European coun-
tries [4-6], at least in part due to differences in care pro-
vided [7]. There is also variation in outcome between
different localities within the UK [8-11], these local dif-
ferences being highlighted in the most recent publica-
tion of the National Sentinel Stroke Audit in 2009 [12].
These differnces probably arise as a result of substantial
variations in how the stroke services are provided across
the UK. Examples of such differences are access to neu-
rovascular/neurosurgical service, early supported
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discharge, and stroke specialist on call rota for thrombo-
lysis. The presence or absence of variations in stroke
outcomes as a result of variation in care and how much
the observed variations in patients’ outcomes including
patient reported outcome measure (PROM) are deter-
mined by the differences in service delivery have not
been examined previously.
We hypothesise that variation in patient outcomes
including mortality, length of stay, institutionalisation
rate, and patient reported outcomes between care provi-
ders can partly be explained by the different ways in
which stroke services are delivered. The main objectives
of the study are (1) to describe variation in outcomes
following stroke and to identify the characteristics of
services that are associated with better outcomes after
accounting for case mix differences and individual prog-
nostic factors, and (2) to obtain preliminary data to
identify sample size and inform future pragmatic real
world setting RCTs in the area of health service delivery
in stroke.
Methods/Design
A prospective cohort study will be conducted to identify
characteristics of services that are associated with the
best outcomes including patient reported outcomes, tak-
ing into account case-mix and patients’ prognostic fea-
tures. The study will consist of two components (1)
consecutive stroke admissions in selected months (a
total of 8 months) and (2) a prospective study of patient
reported outcome in some of these selected months.
Sample Population
For the first component, the sample population will be
stroke patients who are admitted to any of the hospitals
within the Anglia region of Stroke & Heart Clinical Net-
work between October 2009 and September 2011. Base-
line data are already recorded, prior to the study
commencement, as part of routine clinical data collec-
tion by Anglia Stroke Clinical Network (as described in
detail below). The study sample will be a systematically
selected sample (every third month) rather than a conse-
cutive cohort of patients admitted to eight acute NHS
hospital trusts. Therefore, this is not a consecutive case
study; instead it seeks to be representative of the catch-
ment population of the hospital and has taken into
account the seasonal variation in stroke incidence and
outcome [13].
For the patient reported outcome component of the
study the following inclusion and exclusion criteria will
be used. Inclusion criteria are (1) age > = 18 years, (2)
admitted to hospital with stroke (diagnosed by stroke
physicians) during the study months, (3) able to provide
informed consent or patient’s personal consultee agrees
to study participation. Exclusion criteria include (1) age
<18 years, (2) patients with pre-existing diagnosis of
dementia (for PROM component only).
The Anglia Stroke Network was funded through the
NHS Improvement Programme, following the publica-
tion of the National Stroke Strategy in December
2007. The Network was established in April 2008 to
support the development of stroke services in Norfolk,
Suffolk and Cambridgeshire regions. Since its incep-
tion, the Network regularly collected data to capture
clinical service activities of the eight acute hospital
trusts in the Network for the purpose of monitoring
of services benchmarked by National targets and gui-
dance from National Institute of Health & Clinical
Excellence (NICE) in England and Wales. Data collec-
tion commenced in January 2009 and involves the
individual trusts collecting clinical data which is fed
back to the network by monthly reports. The total
number of strokes admitted to the 8 acute trusts
within the Network is approximately 4,000 per annum
in 2009. The stroke cases were identified prospectively
data were collected by the clinical team who looked
after the patients and anonymised raw clinical data
were sent to the network on monthly basis. The net-
work collates and analyses the data for above men-
tioned purposes.
Sample size
Since this is an exploratory study designed to provide
information for further analytic research, sample size
will be determined partly pragmatically rather than on
particular hypothesis tests. For illustration purposes, a
total sample of 2264 patients would provide 80% power
to detect a constant Hazard ratio (HR) of 0.76 for one-
year mortality between two groups of roughly equal size,
based on the log-rank test. This assumes a 20% one-year
mortality rate in the reference group, no loss to follow-
up before one year and 2-sided type I error of 5%. If
one-year mortality is 30%, then 2264 patients would
provide 76% power to detect a HR of 0.81.
Plan of investigation
The study will have a cohort design. We will follow up
a cohort of patients systematically selected from each
trust. For pragmatic purposes we will sample all
patients who are admitted every third month, starting
from October 2009. Over one calendar month, there
will be ~ 300-350 stroke cases entered into the Net-
work Clinical Data. Between October 2009 and
September 2011, the Clinical Network would have
collected a total of eight 3-monthly datasets per trust
(i.e. 8 study months in total: Oct 2009, Jan 2010, April
2010, July 2010, October 2010, Jan 2011, April 2011,
July 2011). Therefore, the estimated total cohort size
with baseline clinical data will be ~ 2,400 stroke cases
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during this exercise (30% of 4000 patients admitted
annually in 8 trusts = 1200 × 2 yrs).
We will collect patient data by hospital trusts and
conduct a questionnaire survey of patients’ outcomes.
Due to the nature of the study we would need 100% fol-
low-up in randomly selected populations. Because we
will be using a partially historical cohort, to avoid selec-
tion bias for mortality outcome, informed consent from
all eligible participants will not be feasible. Therefore, it
is most appropriate for the clinical team to collect the
outcome data to comply with current ethical guidance
in the UK. Therefore, the identifiable patient data will
only be held at the local NHS trusts.
Neither the network nor the investigators will have
access to any identifiable patient information (e.g. name,
address). For outcome data we will utilise death certificate
and hospital episode data from the Patient Administrative
System (PAS) as described previously [14,15]. This
approach will be used in conjunction with telephone and
postal follow-up for questionnaire surveys such as EQ-5
D, and Stroke Impact Scale. These data will be counter-
checked using discharge coding records, which record
each hospital episode.
The clinical teams will retrieve case records to collect
(1) baseline measures which were not recorded in base-
line Network surveys and (2) outcome measures includ-
ing mortality and hospital length of stay. At study
commencement (October 2010) one year follow up data
can be collected immediately for October 2009 cohorts
(follow up complete at end September 2010). The follow
up will be completed in September 2012 as the stroke
patients included in the last survey for the study con-
ducted by the Network in July 2011 will complete one
year follow-up in June 2012 and data collection of the
study will be completed by July-August 2012 with
the view of final cohort data arrival to research team by
the end of December 2012.
Due to multi-centre nature of the study the individual
sites are expected to join the study at different time
points (after their respective NHS Research & Develop-
ment Committees’ approval). We will collect character-
istics of stroke services, patient related factors,
prognostic indicators, treatment options and trial/study
participation. Missing prognostic data will be imputed
statistically, to ensure that all eligible patients are
included in the primary analysis (see also Statistical
Methods).
The service characteristics of interest include:
At hospital level
• staffing (including junior doctors and therapists (whole
time equivalent), physicians characteristics
• university or district general hospital
• distance from tertiary referral centre
• availability of vascular surgery on site, neuro-surgery
and neuro ITU on site
• monitoring beds
• physician on call rota
• compliance with NICE guidelines
At patient level
• provision of thrombolysis and CT
• medication
Outcome measurements
Primary outcome of the study will be one year mortality
comparison between services with different characteris-
tics. The secondary outcomes will include (1) final
discharge destination (good or poor outcome) [16],
(2) length of acute hospital stay, (3) length of stay in
rehabilitation, (4) complications during acute and rehab-
hospital stay and significant procedures (e.g. aspiration
pneumonia, myocardial infarction), (5) readmissions,
(6) composite cardiovascular events (recurrent TIA/
Stroke/Acute Coronary Syndrome, Myocardial infarction).
Patient Reported Outcome Measures (PROM)
PROM will consist of (1) Stroke Impact Scale, (2) health
related quality of life: EQ-5 D at one year in those who
completed questionnaire at the baseline, (3) modified
RANKIN, (4) Barthel score and (5) health service use.
Statistical analysis
Quantitative data will be analysed by multivariate Cox-
proportional hazards to examine the relationships between
different aspects of health services and time to death,
adjusting for prognostic characteristics. Multiple logistic
or linear regression models will be constructed as appro-
priate for dichotomised and continuous outcome variables
respectively. T tests for normally distributed data and
Mann-Whitney U tests for non-normally distributed data
will be used to compare continuous outcomes. Volume-
outcome relationships will be investigated. Missing prog-
nostic and EQ-5 D data will be imputed, based on each
patient’s other prognostic characteristics. Clustering of
data by hospital trust will be investigated and, if necessary,
taken into account, and intra-class correlation coefficients
calculated to inform future research.
Economic evaluation
Health care resources are scarce and it is therefore
important to ensure that evaluations are undertaken in
order to ensure that services provided by the NHS con-
stitute value for money. Within this study we will
thereby seek to estimate the cost-effectiveness of differ-
ent stroke service deliveries.
Costs will first be calculated from the perspective of
the NHS and personal social services (PSS). Thus, levels
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of resources use will be recorded during the follow-up
period, including the length of original hospital stay,
input by the multi-disciplinary team, other investigations
(e.g. x-ray) and any complications (including details of
any further hospital admissions). Unit costs will subse-
quently be assigned to each of these resource items,
enabling both the total mean cost in participants and
the incremental cost between two different service deliv-
eries (chosen to compare the cost effectiveness, e.g. tra-
ditional on call rota vs. telemedicine) to be calculated
after adjusting for other factors. The main measure of
effectiveness to be used in the economic analysis will
the EQ-5 D [17], where responses will be sought at
baseline, and at 12 month as mentioned above. This will
enable the overall effect of each mode of service deliv-
ery, and the incremental effect of services to be
estimated.
Outcome
As the National Institute of Health and Clinical Excel-
lence [18] recommends use of the EQ-5 D [17] within
cost-effectiveness analysis this will be our primary
measure within the economic analyses. EQ-5 D data
will be collected at two University Hospitals and two
district general hospitals within the clinical network.
We will use “mapping” strategy to estimate the cost-
effectiveness analyses across the region. The use of
mapping, where scores from a condition-specific (non
preference-based) measure are ‘converted’ into a utility
(preference-based) score using a pre-defined formulae,
has been advocated (in certain instances) by the UK
National Institute of Health and Clinical Excellence
(NICE) [18], and has been used to estimate the utility
scores, and in turn cost-effectiveness, of a number of
health care interventions [19]. Mapping presents the
possibility of not asking all participants to complete
the EQ-5 D. In this study we propose to take advan-
tage of this by developing a mapping algorithm based
on the response from participants participating in this
component to predict the EQ-5 D for participants in
retrospective cohorts and those who did not participate
in PROM component.
Because the quality of life measure (EQ-5D) which can
be used to estimate health utility and calculate QALYs
(Quality Adjusted Life Years) for economic evaluation is
outside the remit of routine data collection and cannot
be done retrospectively, we will collect EQ-5 D data in
only the second year of the study (October 2010 and
January, April and July 2011 cohorts and one year follow
up data to be collected September and December 2011,
and March and June 2012) in those who provide
informed consent to the study (we estimate that the
sample will be approximately 15-20% of the whole sam-
ple after excluding the one year pre-study period
(between October 2009-September 2010) and after
taking into account of refusal rate (estimated ~ 30%) in
trusts with Stroke or Comprehensive Local Research
Network Research Nurses.
Economic Analysis
In the Economic analysis if one option is shown to be
less costly and more effective than another option (for
example, telemedicine vs. on call system) then that
option will ‘dominate’ the other and be deemed cost-
effective. Alternatively, the incremental cost-effectiveness
ratio (ICER) associated with a particular option will be
estimated and assessed in relation to a range of cost-
effectiveness thresholds. The associated level of uncer-
tainty will also be characterised by e.g. estimating the
cost-effectiveness acceptability curve (CEAC) for each
intervention and conducting value of information analy-
sis [20]. Sensitivity analysis will also be undertaken to
assess the robustness of conclusions to key assumptions.
We will also seek to identify what resource items should
be monitored in a future study (i.e. what are the big
cost drivers which are likely to be affected by the inter-
vention) and how these items should be identified.
The study is funded by the NIHR Research for Patient
Benefit Programme (PB-PG-1208-18240) and obtained
ethical approval from the Norfolk Research Ethics
Committee.
Discussion
In this study we specifically aim to identify services that
are associated with the best clinical outcomes including
mortality and hospital length of stay including patient
reported outcome adjusting for patient prognostic fac-
tors and potential confounders. Our study will be able
to provide useful information in stroke service provision
in UK and beyond. Furthermore, inclusion of patient
reported outcome is novel and exciting component of
our study.
Studies which have examined the delivery of specific
services such as rapid imaging, have shown improvement
in patients’ outcome in stroke [21]. A recent report from
Germany suggested that a telestroke network may be a
useful strategy to implement in their non-urban stroke
services [22]. Lees et al (2008) [23] highlighted that there
is room for improvement in terms of acute services for
stroke. Interestingly, one of the observations was that
centres with higher workload performed better. There is
also existing evidence in Cancer literature that centres
with higher surgical caseload have better outcomes [24].
There has also been a recent evaluation of the impact on
stroke outcome by evidence-based practice in an Austra-
lian setting [25]. Examples of service delivery that are
associated with better outcomes include organised stroke
unit care [26], thrombolysis treatment and appropriate
secondary prevention [27], and early supported discharge
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in selected patients [28,29]. However, the cost-effective-
ness of such services has yet to be fully examined.
Rodgers et al [30] highlighted the need for improve-
ment in hospital-based stroke services e.g. stroke unit
staffing levels were lower than was available in RCTs.
The accumulating body of evidence has been a major
driving force behind the UK Government’s strategy to
improve stroke care (National Stroke Strategy, 2007)
[31]. A key strand of the strategy was to set up stroke
networks to deliver stroke service development across
geographically defined areas. The stroke networks have
worked to agree minimum standards for stroke care and
they have worked with commissioners to assist the com-
missioning process for stroke services. The acute stroke
services are currently delivered by different NHS trusts
and there is therefore a wide range of inequality in ser-
vice availability and provision with differeing structure
and local support systems.
This research aims to utilise NHS data in the most
meaningful and innovative way and we aim to maximize
the benefit with minimum investment to produce best
research output for patient care by collaborating with
clinical teams and the network in providing excellent
value for money. This observational study seeks to iden-
tify areas of clinical practice which merit future rando-
mised controlled trials (RCTs) to identify best practice
in improving stroke care which will be of maximum
benefit to patients. We also aim to obtain preliminary
data to estimate sample sizes and conduct value of
information analyses to design future pragmatic RCTs
of innovative ways of delivering stroke care.
As we include eight diverse NHS trusts, the findings
are likely to be generalisable in the UK setting and
beyond. This study will provide observational data about
health service factors associated with variations in
patient outcomes and health care costs following hospi-
tal admission for acute stroke. This will form the basis
for future RCTs by identifying promising health service
interventions, assessing the feasibility of recruiting and
following up trial patients, and provide evidence about
frequency and variances in outcomes, and intra-cluster
correlation of outcomes, for sample size calculations.
The results will also inform clinicians, public, service
providers, commissioners and policy makers to drive
further improvement in health services and bring direct
benefit to patients.
The study will describe the variation in outcomes
between different stroke services, and identify the char-
acteristics of services associated with better outcomes
after accounting for case-mix. We will also estimate the
relative costs of and health gain estimated as Quality
Adjusted Life Year (QALY) gain that may be demon-
strated by different services. The commissioners of ser-
vices will be informed as to which service delivery
structures are likely to provide value for money to make
purchasing decisions. They will also be better informed
about the types of service associated with better patient
reported outcome. Hospital trusts will be able to evalu-
ate their services systematically and plan their care
appropriately to meet local and regional needs and
demands based on our study findings. Professionals will
be able to reflect on the impact of services they are deli-
vering to help improve their performance and the way
services are organised by adopting the most effective
and cost effective approaches. As an observational study,
the study limitations include inability to control for
unknown confounders and residual confounding effect
of known confounders which are adjusted for. The cau-
sal relationship cannot be implied but as we stated the
findings will provide knowledge about areas that
requires further evaluation in clinical trial setting.
There is very little work which assesses service provision
robustly against patients’ own reported outcomes. This
exciting study may lead to a clearer drive for patients to
define what makes a good service. We hope that the best
clinical practices are adopted to suit the local populations’
needs and demand. As we included eight diverse NHS
trusts, the findings will be generalisable in the UK setting
and likely to be applicable in international setting. All
these will become drivers of improvement in stroke ser-
vices for the benefit of stroke sufferers.
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